Cancer and disparities in health: Perspectives on health statistics and research questions

Cancer

Volumn 113, Issue 7, 2008, Pages 1744-1754

  Brawley, Otis W ^a,b   Berger, Mitchell Z ^c  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; ETHNICITY; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RACE DIFFERENCE; SOCIOECONOMICS; SURVIVAL RATE; UTERINE CERVIX CANCER;

FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; NEOPLASMS; POVERTY; SOCIOECONOMIC FACTORS;

EID: 53949112060     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23800     Document Type: Note

References (61)

1. Henschke UK, Leffall LD Jr, Mason CH, Reinhoid AW, Schneider RL, White JE. Alarming increase of the cancer mortality in the US black population (1950-1967). Cancer. 1973;31:763-768.
2. Ries LAG, Eisner MR Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute; 2005. Available at:http://seer.cancer.gov/csr/1975-2002. Accessed on March 1, 2008.
3. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2005 (based on November 2007 SEER data submission, posted to the SEER website, 2008). Bethesda, Md: National Cancer Institute; 2007. Available at: http://seer.cancer.gov/csr/1975_2005. Accessed on April 28, 2008.
4. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring. J Natl Cancer Inst. 2005;97:1407-1427.
5. Goldson A, Henschke U, Leffall LD, Schneider RL. Is there a genetic basis for the differences in cancer incidence between Afro-Americans and Euro-Americans? J Natl Med Assoc. 1981;73:701-706.
6. United States Congress. NIH Revitalization Act of 1993. Public Law 103-43. Washington, DC: June 10, 1993.
7. Ries LAG, Harkins D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2003. Bethesda, Md: National Cancer Institute; 2006. Available at: http://seer.cancer.gov/csr/1975-2002. Accessed on April 28, 2008.
8. Brawley OW. Some perspective on black-white cancer statistics. CA Cancer J Clin. 2002;52:322-325.
9. Brawley OW. Population categorization and cancer statistics. Cancer Metastasis Rev. 2003;22:11-19.
10. Brawley OW. The study of untreated syphilis in the Negro male. Int J Radiat Oncol Biol Phys. 1998;40:5-8.
11. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85:1819-1827.
12. Singh GK, Miller BA, Hankey BF, and Edwards BK. Area Socioeconomic Variations in US Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer Surveillance Monograph Series, No. 4. NIH Publication No. 03-5417. Bethesda, Md: National Cancer Institute; 2003.
13. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99:1384-1394.
14. Satia-Abouta J, Patterson RE, Neuhouser ML, Elder J. Dietary acculturation: applications to nutrition research and dietetics. J Am Diet Assoc. 2002;102:1105-1118.
15. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
16. McLaren G, Bain M. Deprivation and Health in Scotland: Insights From NHS Data. Edinburgh: ISD Scotland; 1998.
17. Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev. 2003;22:55-65.
18. Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Commun Health. 2001;55:308-315.
19. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement on hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148:932-938.
20. Beutler E, Lisker R, Kuhl W. Molecular biology of G 6 PD variants. Biomed Biochim Acta. 1990;49:S236-S241.
21. Wall TL, Peterson CM, Peterson KP, et al. Alcohol metabolism in Asian-American men with genetic polymorphisms of aldehyde dehydrogenase. Ann Intern Med. 1997;127:376-379.
22. Hotta K, Kiura K, Takigawa N, et al. Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer. Lung Cancer. 2008 May 14. [Epub ahead of print.]
23. Gupta E, Mick R, Ramirez J, et al. Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients. J Clin Oncol. 1997; 15:1502-1510.
24. Akerley WL III, Moritz TE, Ryan LS, Henderson WG, Zacharski LR. Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med. 1993;153:1681-1688.
25. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
26. Graham MV, Geitz LM, Byhardt R, et al. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. J Natl Cancer Inst. 1992;84:1731-1735.
27. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. Social factors, treatment, and survival in earlystage non-small cell lung cancer. Am J Public Health. 1998;88:1681-1684.
28. Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 1995;13:235-252.
29. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer. 1996;77:1947-1955.
30. Earle CC, Venditti LN, Neumann PJ, et al. Who gets chemotherapy for metastatic lung cancer? Chest. 2000;117:1239-1246.
31. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2502.
32. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008;109:545-557.
33. Griggs JJ, Culakova E, Sorbero ME, et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol. 2007;25:277-284.
34. Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis. 2007;28:2154-2159.
35. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652-658.
36. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer in Five Continents, 7th ed. Lyon, France: IARC; 2005.
37. Amling CL, Riffenburgh RH, Sun L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22:439-445.
38. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology. 2001;58:723-728.
39. Harlan LC, Coates RJ, Block G, et al. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology. 1993;4:25-31.
40. Rodriguez C, McCullough ML, Mondul AM, et al. Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2006;15:211-216.
41. Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J Urol. 2007;178:1939-1944.
42. Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998;16:3101-3104.
43. Wolf MS, Knight SJ, Lyons EA, et al. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006;68:89-93.
44. Tarman GJ, Kane CJ, Moul JW, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 2000;56:1016-1020.
45. Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106:1276-1285.
46. Hoffman RM, Harlan LC, Klabunde CN, et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med. 2003;18:845-853.
47. Beart RW, Steele GD Jr, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg. 1995;181:225-236.
48. Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996;34:970-984.
49. Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996;86:582-586.
50. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686-1693.
51. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90:1746-1754.
52. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850-857.
53. Tropman SE, Hatzell T, Paskett E, Ricketts T, Cooper MR, Aldrich T. Colon cancer treatment in rural North and South Carolina. Cancer Detect Prev. 1999;23:428-434.
54. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008;100:738-744.
55. Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007; 109:2161-2170.
56. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999;94:509-515.
57. Merrill RM, Merrill AV, Mayer LS. Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women. Ethn Dis. 2000;10:248-256.
58. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A and stage 1A cervical cancer: a SEER database study. Gynecol Oncol. 1999;75:113-117.
59. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2138-2139.
60. Shavers VI, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94:334-357.
61. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008;112:900-908.